Maximize Insights and Minimize Uncertainty with our Enhanced Hereditary Cancer Testing Portfolio
The evidence-informed, flexible tests you need to find answers for your patients.
Our enhanced menu offers a flexible approach to genetic testing, informed by guidelines and scientific evidence. This comprehensive portfolio will deliver the clinical insights you need, paired with the exceptional support and patient access you have come to expect from Ambry.
Key Updates
Multiple tests designed based on consensus management guidelines for maximized clinical utility.
New indications and genes added for more comprehensive genetic assessment.
Enhancements to improve flexibility and ease-of-use, including new addon options and an easier approach to ordering all cancer predisposition genes on the menu.
+RNAinsight®, paired DNA/
RNA testing, remains available
for order in combination with
any genes on the hereditary
cancer menu.1
- Not available for STAT testing or with BRCAPlus®
Questions? Contact Us.
info@ambrygen.com (949) 900-5500